Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy

INTRODUCTION: Complete pathologic response (CPR) is an acceptable surrogate for survival in clinical trials but it occurs infrequently in patients with NSCLC receiving neoadjuvant chemotherapy (NCT). Therefore, we studied the impact of major pathologic response (MPR) for predicting survival of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Pataer, Apar, Weissferdt, Annikka, Correa, Arlene M., Vaporciyan, Ara A., Sepesi, Boris, Heymach, John V., Berezowska, Sabina, Cascone, Tina, Swisher, Stephen G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646962/
https://www.ncbi.nlm.nih.gov/pubmed/36389133
http://dx.doi.org/10.1016/j.jtocrr.2022.100420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646962/
https://www.ncbi.nlm.nih.gov/pubmed/36389133
http://dx.doi.org/10.1016/j.jtocrr.2022.100420

Ejemplares similares